Nathaniel Mabe,PharmD,PhD
@nathaniel_mabe
Assistant professor, Purdue MCMP | Interested in epigenetic plasticity in pediatric solid tumors
ID: 1268615022638510080
https://www.mabelabpurdue.com/ 04-06-2020 18:46:14
48 Tweet
262 Followers
346 Following
With 3 approved epigenetic drug classes and many more under clinical investigation, epigenetic targets are gaining traction. Here, we take survey of developments and hurdles in targeting the cancer epigenome. Thank you Nature Cancer for the opportunity nature.com/articles/s4301…